
Tumor lysis syndrome (TLS) is a potentially life-threatening metabolic disorder characterized by an elevated uric acid level, elevated serum potassium and phosphorus levels, and a decreased calcium level.

Your AI-Trained Oncology Knowledge Connection!


Published: August 27th 2012 | Updated: